Loading
No insider purchase over the last 90 days. The latest, by Phelan Kenneth J, was filed 27 Jan 2026.
Insider Decl.
10
Thresholds
n/a
Buy Volume
€86,363
8 ops. · all time
Sell Volume
€43,466
2 ops. · all time
Who traded when
BuySaleKenneth J. Phelan1 buy
Noni L. Ellison1 buy
Thomas Rowe Wright1 buy
William K. Bacic1 buy
Since the insiders bought
- -8.7%Entry US$12.94 · Close 19 Oct 2026 US$11.82
- +11.5%Entry US$12.02 · Close at T+365 US$13.40
- +0.8%Entry US$12.71 · Close at T+365 US$12.81
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended October 2025 · cache
US$11.86
Analyst consensus
Income statement
RevenueUS$70.5M
Gross profitUS$1.2B1766% margin
EBITDAUS$405.2M575% margin
Net incomeUS$68.5M210.2% margin
Valuation
PER (trailing)4.7x
P/Book0.8x
Beta0.71
Balance sheet & cash
Market capUS$583.3M
Total debtUS$373.7M
Free Cash FlowUS$48.5M
Debt / Equity51%
Profitability & ownership
ROE18.1%
ROA2.9%
% insiders0.0%
% institutions15.7%
Last declaration on 27 January 2026
Declarations10 total
774.071 shares@ US$12.92100.0% of flowCommon Shares of Beneficial InterestSEC:0001779467-26-000007:0
Canonical exit: 26 Apr 2026 (T+90)
929 shares@ US$11.8475100.0% of flowCommon Shares of Beneficial InterestSEC:0001950731-25-000034:0
Canonical exit: 7 Jul 2025 (T+90)
800 shares@ US$12.55100.0% of flowcommon shares of beneficial interestSEC:0001992593-25-000005:0
Canonical exit: 14 Apr 2025 (T+90)
890 shares@ US$12.6450.6% of flowcommon shares of beneficial ownershipSEC:0002048097-24-000004:0
Canonical exit: 23 Mar 2025 (T+90)
1,336.78 shares@ US$12.03100.0% of flowCommon Shares of Beneficial InterestSEC:0001561793-24-000008:0
Canonical exit: 1 Apr 2024 (T+90)
1,185 shares@ US$9.34849.4% of flowCommon Shares of Beneficial InterestSEC:0001561793-23-000023:0
Canonical exit: 10 Jan 2024 (T+90)
2,611 shares@ US$15.66100.0% of flowcommon shares of beneficial interestSEC:0001228616-22-000032:0
715 shares@ US$13.975100.0% of flowcommon shares of beneficial interestSEC:0001228616-20-000037:0
Canonical exit: 15 Feb 2021 (T+90)
244 shares@ US$16.40100.0% of flowcommon shares of beneficial interestSEC:0001228616-16-000090:0
1,103 shares@ US$13.6154100.0% of flowcommon shares of beneficial interestSEC:0001228616-16-000058:0
Canonical exit: 3 Apr 2016 (T+90)
10 of 10 declarations
About John Hancock Premium Dividend Fund
John Hancock Premium Dividend Fund, classed in Finance & Banking and valued at USD 583.3 million, has only 10 filings from 9 filers in ten years, including 8 purchases worth EUR 86,363 (median EUR 10,268) and 2 sales worth EUR 43,466. Purchases are 80% of open-market trades.
The largest purchase, EUR 14,568, is director Dean Garfield's on January 2, 2024; James Boyle bought EUR 13,836 on January 4, 2016 and Noni L. Ellison, a director, EUR 10,783 on December 23, 2024. The latter signs 2 filings, both purchases. Between December 23, 2024 and January 14, 2025, 2 filers bought for EUR 20,563. Kenneth J. Phelan, Thomas Rowe Wright and William K. Bacic each filed one purchase.
Read moreShow less
The two sales are Steven R. Pruchansky's (EUR 39,900 on August 5, 2022) and Hassell H. Mcclellan's (EUR 3,567 on September 30, 2016). Annual volume never exceeds 2 filings. The last was published on January 27, 2026, a purchase, the only filing of the last twelve months. The median publication delay is 2 days.
